http://rdf.ncbi.nlm.nih.gov/pubchem/reference/33724412

Outgoing Links

Predicate Object
contentType Journal Article|Review
endingPage 543
issn 0957-9672
issueIdentifier 6
pageRange 536-543
publicationName Current Opinion in Lipidology
startingPage 536
bibliographicCitation Rankin W, Wittert G. Anti-obesity drugs. Curr Opin Lipidol. 2015 Dec;26(6):536–43. doi: 10.1097/mol.0000000000000232. PMID: 26382553.
creator http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0001-6818-6065
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b00ccfac87cfc734e8d1fc0fbf7354f0
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_71d29f395c9597534b8d80d03bee1e3c
http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-4427-9547
date 201512
identifier https://doi.org/10.1097/mol.0000000000000232
https://pubmed.ncbi.nlm.nih.gov/26382553
isPartOf https://portal.issn.org/resource/ISSN/0957-9672
http://rdf.ncbi.nlm.nih.gov/pubchem/journal/8514
language English
source https://www.crossref.org/
https://pubmed.ncbi.nlm.nih.gov/
title Anti-obesity drugs
discusses http://id.nlm.nih.gov/mesh/M0028922
hasPrimarySubjectTerm http://id.nlm.nih.gov/mesh/D019440Q000494
http://id.nlm.nih.gov/mesh/D019440Q000627
http://id.nlm.nih.gov/mesh/D009765Q000188
hasSubjectTerm http://id.nlm.nih.gov/mesh/D055808
http://id.nlm.nih.gov/mesh/D006801
http://id.nlm.nih.gov/mesh/D000818
http://id.nlm.nih.gov/mesh/D002986
discussesAsDerivedByTextMining http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5284627
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11658860
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5360515
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9710
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID444
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8102
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4771
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7444
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8679
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7181
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID16134956

Showing number of triples: 1 to 40 of 40.